PFM
WST icon

Patton Fund Management’s West Pharmaceutical WST Stock Holding History

Patton Fund Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-863
Closed -$216K – 473
2026
Q1 		$216K Buy
863
+78
+10% +$19.4K 0.04% 444
2025
Q4 		$216K Sell
785
-183
-19% -$50.1K 0.03% 418
2025
Q3 		$254K Buy
+968
New +$235K 0.05% 251
2022
Q2 		– Sell
-8,616
Closed -$3.54M – 97
2022
Q1 		$3.54M Buy
+8,616
New +$3.37M 0.97% 32

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Patton Fund Management's WST Position: Q2 2026 in Review

Patton Fund Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 863 shares — an estimated $216K sold.

Patton Fund Management first reported a position in WST in Q1 2022 and held it in 4 quarters. The position peaked at $3.54M in Q1 2022. 120 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Patton Fund Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 863 West Pharmaceutical shares in Q2 2026, an estimated $216K.
  • Patton Fund Management first reported a position in West Pharmaceutical in Q1 2022 and held it in 4 quarters.
  • Patton Fund Management's West Pharmaceutical position peaked at $3.54M in Q1 2022.
  • 120 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.